Haoxi Health Technology Ltd. has announced a securities purchase agreement, under which it will issue and sell ordinary shares to selected purchasers. The agreement is structured to comply with exemptions from registration requirements and includes provisions for electronic settlement and necessary regulatory filings. The company has also taken steps to ensure that anti-takeover protections do not impede the transaction.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Haoxi Health Technology Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-100047), on October 17, 2025, and is solely responsible for the information contained therein.
Comments